HSTC Stock Overview
HST Global, Inc., an integrated health and wellness biotechnology company, develops and/or acquires a network of wellness centers for the homeopathic and alternative treatment of late stage cancer in the United States and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
HST Global, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.94 |
| 52 Week High | US$1.15 |
| 52 Week Low | US$0.10 |
| Beta | -0.99 |
| 1 Month Change | 10.59% |
| 3 Month Change | 77.33% |
| 1 Year Change | 840.00% |
| 3 Year Change | 840.00% |
| 5 Year Change | 944.44% |
| Change since IPO | -99.46% |
Recent News & Updates
Recent updates
Shareholder Returns
| HSTC | US Biotechs | US Market | |
|---|---|---|---|
| 7D | -16.1% | 0.4% | 1.0% |
| 1Y | 840.0% | 0.9% | 21.9% |
Return vs Industry: HSTC exceeded the US Biotechs industry which returned 0.7% over the past year.
Return vs Market: HSTC exceeded the US Market which returned 24.9% over the past year.
Price Volatility
| HSTC volatility | |
|---|---|
| HSTC Average Weekly Movement | n/a |
| Biotechs Industry Average Movement | 11.6% |
| Market Average Movement | 6.0% |
| 10% most volatile stocks in US Market | 16.8% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: HSTC's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine HSTC's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Ron Howell | www.hstglobal.com |
HST Global, Inc., an integrated health and wellness biotechnology company, develops and/or acquires a network of wellness centers for the homeopathic and alternative treatment of late stage cancer in the United States and internationally. The company also focuses on the homeopathic and alternative product candidates that are undergoing or have already completed clinical testing for the treatment of late stage cancers and other life-threatening diseases. HST Global, Inc. is headquartered in Hampton, Virginia.
HST Global, Inc. Fundamentals Summary
| HSTC fundamental statistics | |
|---|---|
| Market cap | US$4.93m |
| Earnings (TTM) | -US$146.21k |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-33.7x
P/E RatioIs HSTC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HSTC income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$146.21k |
| Earnings | -US$146.21k |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.028 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | -16.6% |
How did HSTC perform over the long term?
See historical performance and comparison